Ibere Pharmaceuticals is a blank check company that intends to target pharmaceutical companies or life sciences companies with strong international brands. PIPV Capital, a private equity firm focused on healthcare, created this SPAC, which is incorporated in the Cayman Islands.)

Osagie Imasogie, our chairman and CEO, is a co-founder and senior managing partner of PIPV Capital. He was previously the founding vice president of GlaxosmithKline Ventures.

Lisa Gray, our CFO, and Zoltan Kerekes, our COO, are co-founders and managing partners of PIPV Capital.

(Note: Ibere Pharmaceuticals upsized its SPAC IPO at pricing on Feb. 25, 2021: 12 million units, up from 10  million, were priced at $10 each to raise $120 million.)